Not available
Quote | ARCA biopharma Inc. (NASDAQ:ABIO)
Last: | $3.61 |
---|---|
Change Percent: | 2.11% |
Open: | $3.72 |
Close: | $3.61 |
High: | $3.96 |
Low: | $3.61 |
Volume: | 184,771 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
News | ARCA biopharma Inc. (NASDAQ:ABIO)
NEW YORK, NY / ACCESSWIRE / May 22, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Squarespace, Inc. (NYSE:SQSP)'s sale...
2024-05-14 13:48:14 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Yesterday, the forgotten meme stocks of 2021 started picking up serious momentum. But unlike 2021, it didn’t take much to see the reason behind GameStop’s (NYSE: GME...
Message Board Posts | ARCA biopharma Inc. (NASDAQ:ABIO)
Subject | By | Source | When |
---|---|---|---|
ASPEN-COVID-19 Data and Safety Monitoring Committee Recommends Continuing | INFINITI | investorshub | 10/29/2021 11:35:26 AM |
ARCA biopharma shares surge 30% on positive DSMC | INFINITI | investorshub | 10/29/2021 11:33:58 AM |
Looks good got some $$$ | INFINITI | investorshub | 10/29/2021 11:33:20 AM |
whytestocks: $ABIO News Article - ARCA biopharma to Present at Access to Giving Virtual Investor Con | whytestocks | investorshangout | 07/09/2021 3:51:00 PM |
whytestocks: $ABIO News Article - ARCA biopharma Announces rNAPc2 COVID-19 Patent Assignment Agreeme | whytestocks | investorshangout | 07/07/2021 5:57:41 PM |
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, NY / ACCESSWIRE / May 22, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Squarespace, Inc. (NYSE:SQSP)'s sale...
ARCA biopharma and Oruka Therapeutics announce Merger Agreement ARCA biopharma appoints Thomas Keuer as President WESTMINSTER, Colo., April 25, 2024 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), (the “Company”) a biopharmaceutical company app...